top of page

P&G’s Governance Model: A Powerful CEO, a CEO-Heavy Board, and Jimenez as Lead Director

  • Writer: Merlin @GovernanceCentral
    Merlin @GovernanceCentral
  • Jul 30
  • 9 min read

Procter & Gamble’s latest leadership change is more than a routine boardroom update. It shows how P&G balances executive authority, board independence, and the need for directors who can add real business value.


On July 29, 2026, P&G announced that Shailesh Jejurikar will become Chairman of the Board, effective August 1, 2026, while continuing to serve as President and Chief Executive Officer. Jon Moeller, P&G’s Executive Chairman, will retire from the board effective July 31, 2026, and from the company effective August 14, 2026. [us.pg.com], [financialexpress.com]


In plain English: P&G is putting the CEO and board chair roles back in the hands of one person.


That may sound like a major governance shift. But for P&G, it is better understood as a return to a familiar model: a combined Chair and CEO, balanced by a Lead Independent Director and a board with deep executive experience.


The bigger question is not simply whether the CEO should also chair the board. The better question is this:

If the CEO also chairs the board, does P&G have independent directors who can both oversee management and add meaningful value to the company?

That second part matters. A strong board does not merely say yes or no to management. It improves the quality of the company’s decisions.


What Is Changing at P&G?


The immediate change is simple:


The governance concern is clear. When one person is both CEO and board chair, power is concentrated at the top.


But P&G’s answer is also clear. The company relies on a Lead Independent Director and a board filled with experienced current and former senior executives. At P&G, the Lead Independent Director is Joseph Jimenez, the former CEO of Novartis. [linkedin.com], [cincymagazine.com]


P&G’s Recent Chair and CEO Timeline


The timeline helps explain why this move is not as unusual as it may first appear.

  • 2015-2021: David Taylor served as P&G’s Chairman, President and CEO. In 2020, P&G identified Taylor as Chairman of the Board, President and Chief Executive Officer. [fiercepharma.com]

  • 2018: Joseph Jimenez, former CEO of Novartis, joined the P&G board. P&G now identifies him as Lead Director. [linkedin.com], [assets.ctfassets.net]

  • 2021-end of 2025: Jon Moeller served as P&G’s Chairman, President and CEO. P&G’s leadership biography says Moeller served as Chairman, President and CEO from 2021 until the end of 2025. [assets.ctfassets.net], [marketscreener.com]

  • January 1, 2026-July 31, 2026: Moeller served as Executive Chairman, while Jejurikar served as President and CEO. This temporarily separated the board chair and CEO roles. [assets.ctfassets.net], [us.pg.com]

  • August 1, 2026 onward: Jejurikar becomes Chairman while remaining President and CEO, recombining the roles. [us.pg.com], [financialexpress.com]


The key point: the Moeller-Jejurikar split appears to have been part of a leadership transition, not a permanent change in P&G’s governance philosophy.


How P&G Thinks About Board Leadership


P&G does not treat the separation of Chair and CEO as a fixed rule. The company says its board has discretion to decide whether the same person should serve as both CEO and Chairman or whether the roles should be separated. [cincymagazine.com]


P&G also says the board considers the company’s needs, investor feedback, and practices at similar global companies when deciding which leadership structure to use. [cincymagazine.com]


That means P&G’s approach is flexible. Sometimes it separates the roles. Sometimes it combines them. When the roles are combined, P&G relies on a Lead Independent Director to help maintain independent board leadership. [cincymagazine.com]


This approach is not unusual among large companies. A 2026 Conference Board analysis published through the Harvard Law School Forum found that many companies preserve board discretion to combine or separate the Chair and CEO roles depending on circumstances. [businesswire.com]


Why the Lead Independent Director Matters


When the CEO is also board chair, the Lead Independent Director becomes especially important.


The board is supposed to oversee management. But when the CEO also chairs the board, the person being overseen also has a major role in leading the oversight body. That does not automatically mean governance is weak, but it does mean the independent directors need a strong leader of their own.


P&G’s governance materials say that when the CEO and Chairman roles are held by the same person, or when the Chairman is otherwise not independent, the independent directors elect a Lead Director from among themselves. [cincymagazine.com]


In practical terms, the Lead Independent Director is the board’s independent center of gravity. That person helps ensure that independent directors can meet, discuss management performance, evaluate strategy, and raise concerns without being overly dependent on the CEO-Chair.


But the role should go beyond process. A strong Lead Independent Director should also help the board become more useful to management. The best board leaders do not only police the CEO. They help sharpen strategy, test assumptions, and improve long-term decision-making.


PwC, in a governance memo published through the Harvard Law School Forum, argues that effective board leaders help turn oversight into “an engine for value creation” by challenging and coaching the CEO, strengthening board culture, refreshing talent, and adapting governance processes to match company strategy. [corpgov.la...arvard.edu]


That is the higher standard for P&G’s board. It is not enough for independent directors to be independent. They must be useful.


Who Is Joseph Jimenez?


Joseph Jimenez is P&G’s Lead Director. He is the former CEO of Novartis, where he served from 2010 to 2018. [linkedin.com], [assets.ctfassets.net]


Before Novartis, Jimenez held leadership roles at H.J. Heinz and ConAgra Foods, giving him experience in both healthcare and consumer products. [linkedin.com], [assets.ctfassets.net]


P&G highlights Jimenez’s corporate governance experience, global perspective, innovation background, risk-management skills, and ability to advise on commercial, marketing, and strategic issues. [linkedin.com]


That background matters because P&G does not just need Jimenez to be a referee. It needs him to be a strategic contributor. Jimenez can add value in several ways:

  • Innovation discipline: Novartis is a science-driven company, and P&G depends heavily on product innovation to defend brand leadership. [linkedin.com], [assets.ctfassets.net]

  • Global perspective: P&G operates across global consumer markets, and Jimenez has led a major global enterprise. [linkedin.com]

  • Consumer and healthcare experience: His background includes Novartis, H.J. Heinz, and ConAgra, giving him a mix of healthcare, packaged goods, and consumer-market experience. [linkedin.com], [assets.ctfassets.net]

  • CEO credibility: As a former global CEO, Jimenez can challenge management as a peer, not merely as an outside observer. [linkedin.com]


That last point is especially important. A Lead Independent Director must be able to work constructively with the CEO while still asking hard questions.


P&G Has a CEO-Heavy Board


P&G’s board is not made up of passive observers. It includes many people who have run large organizations.


P&G discloses that, among directors elected as of October 14, 2025, 8 of 14 directors, or 57%, were current or former public-company CEOs or CFOs. [cincymagazine.com]


The current board includes leaders such as:


This matters because P&G’s governance model depends on the board’s ability to challenge the CEO. But it also depends on the board’s ability to help management think better.


A board with this much senior executive experience can add value in areas such as:

  • consumer behavior,

  • retail execution,

  • pricing strategy,

  • supply chain resilience,

  • digital capability,

  • brand investment,

  • capital allocation,

  • risk management,

  • executive succession,

  • and global market strategy.


This is where the board’s composition becomes more than a governance statistic. It becomes a strategic asset.


Spencer Stuart’s 2025 U.S. Board Index found that S&P 500 boards continue to value seasoned executive experience, with new directors often coming from CEO and financial backgrounds. [bing.com], [local12.com]


That trend supports what P&G appears to be doing. The company is not just building a board that can monitor management. It is building a board that can contribute operating judgment.


Independent Directors Must Add Value, Not Just Oversee


This is the most important point in the P&G governance story.


Independent directors are often discussed as if their main job is to restrain management. That is part of the job, especially when the CEO also chairs the board. But it is not the whole job.


The best independent directors do three things:

  1. They oversee. They hold management accountable, review performance, monitor risks, and protect shareholder interests.

  2. They challenge. They test assumptions, ask whether the strategy is realistic, and push management to explain tradeoffs.

  3. They add value. They bring judgment, pattern recognition, external perspective, and experience that management may not have inside the company.


That third role is crucial. P&G operates in a world of changing consumer habits, retailer pressure, global supply chain complexity, input-cost volatility, brand competition, and evolving expectations around health, sustainability, and digital commerce. A strong board should help the company navigate those issues.


Board oversight of strategy is not supposed to be passive. Governance Central describes board strategy oversight as the responsibility to evaluate strategic direction, challenge management assumptions, approve major decisions, and monitor execution in support of long-term value creation. [governance...entral.com]


The Corporate Governance Institute similarly argues that modern boards are expected to do more than approve management decisions. Directors should engage with strategy, analyze complex issues, and help shape long-term value creation. [thecorpora...titute.com]


That is the right standard for P&G’s independent directors. Their job is not just to prevent mistakes. It is to make the company better.


Why Terry Lundgren and Joseph Jimenez Fit the Pattern


Before Jimenez, Terry Lundgren was a key independent governance figure on the P&G board. Lundgren was the former Chairman, CEO, and Executive Chairman of Macy’s, and he joined the P&G board in 2013. [assets.ctfassets.net]


Lundgren’s background was highly relevant to P&G. Macy’s gave him deep experience in retail, consumers, merchandising, pricing, distribution, and brand positioning, all of which matter directly to a company that sells household and personal-care products through major retail channels. [assets.ctfassets.net]


Jimenez brings a different but complementary background: global healthcare, consumer products, innovation, governance, and risk oversight. [linkedin.com], [assets.ctfassets.net]


The pattern is clear. P&G appears to choose Lead Independent Directors who have enough operating experience and boardroom credibility to act as real counterweights to a powerful CEO.


But they are not only counterweights. They are also value creators.


Lundgren could bring the retailer’s view of the consumer. Jimenez can bring a global CEO’s view of innovation, health, risk, and international markets. In both cases, the Lead Independent Director can help P&G look at itself from the outside in.


Is a Combined Chair and CEO Good or Bad?


The evidence is mixed. A Harvard Business School summary of research on CEO and board chair roles concluded that one-size-fits-all proposals to separate the roles deserve careful consideration because leadership structure can depend on company-specific factors. [d18rn0p25n...dfront.net]


A Stanford Graduate School of Business paper also noted that while an independent chair can improve oversight in theory, separation is not always clearly positive because it can create duplicated leadership, slower decision-making, or confusion when an effective CEO-Chair is already in place. [api.asm.skype.com]


More recent governance research summarized by the Harvard Law School Forum also found that the relationship between combined CEO-Chair structures and company performance is mixed, with no single structure consistently outperforming the other. [sec.gov], [businesswire.com]


So the question is not simply whether one structure is always better. The better question is whether a specific company has the right people, processes, and independent board leadership to make its chosen structure work.


For P&G, that means the focus should be on Jimenez and the independent directors.


The Governance Tradeoff


There are real advantages to combining the Chair and CEO roles. A combined structure can create:

  • clearer accountability,

  • faster decision-making,

  • stronger strategic alignment,

  • and a single public voice for the company.


But there is also a real risk. The risk is that the board becomes too closely aligned with management. If the CEO also chairs the board, independent directors must be especially willing to ask hard questions.


That is why the Lead Independent Director role matters so much at P&G.


The structure works only if Jimenez and the independent directors remain active, informed, willing to challenge management, and capable of adding value beyond compliance.


What Investors Should Watch


Investors should watch how P&G’s board behaves after Jejurikar becomes both Chairman and CEO. Key questions include:

  • Does Jimenez have meaningful influence over board agendas?

  • Do independent directors meet regularly without management present?

  • How does the board evaluate Jejurikar’s performance?

  • Who leads CEO succession planning when the CEO also chairs the board?

  • Does the board revisit the Chair-CEO structure each year?

  • Are directors willing to challenge management on strategy, restructuring, pricing, capital allocation, and portfolio decisions?

  • Do independent directors bring useful external perspective to major decisions?

  • Is the board helping management think through innovation, supply chain, consumer behavior, and global growth?

  • Are directors adding value, or merely approving management’s recommendations?


That last question may be the most important one.


A board can be independent and still not be very useful. P&G’s model requires more. It requires independent directors who can both challenge and improve management’s thinking.


The Bottom Line


P&G is not making an unusual experiment. It is returning to a structure it has used before: one person serving as both Chairman and CEO, supported by a Lead Independent Director and a board with deep CEO and CFO experience.


That model will not satisfy everyone. Some investors prefer a permanently independent board chair. That is a reasonable position.


But P&G’s approach is consistent. The company believes a combined Chair-CEO structure can work if the independent board is experienced, engaged, and led by a strong Lead Independent Director.


The key point is that independent directors must do more than oversee. They must add value.


So the next test of P&G governance is not only whether Shailesh Jejurikar can lead the company. It is whether Joe Jimenez and the independent directors can help make P&G better while still holding management accountable.


Jejurikar will hold the power seat. Jimenez will be the counterweight. The board’s job is to make sure that balance produces not just oversight, but better decisions


See the Board Chair Leadership Challenge (TM) boardroom simulation.

Comments

Commenting on this post isn't available anymore. Contact the site owner for more info.
bottom of page